Articles dans des revues avec comité de lecture (260)
  1. 130. Németh, Z. H., Csóka, B., Wilmanski, J., Xu, D., Lu, Q., Ledent, C., Deitch, E. A., Pacher, P., Spolarics, Z., & Haskó, G. (2006). Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. The Journal of immunology, 176(9), 5616-5626.
  2. 131. Short, J. L., Ledent, C., Drago, J., & Lawrence, A. J. (2006). Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors. Biological psychiatry, 31(3), 525-534. doi:10.1038/sj.npp.1300852
  3. 132. Godfrey, L., Yan, L., Clarke, G. D., Ledent, C., Kitchen, I., & Hourani, S. (2006). Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice. European journal of pharmacology, 531(1-3), 80-86. doi:10.1016/j.ejphar.2005.12.004
  4. 133. Castañé, A., Célérier, E., Martín, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2006). Development and expression of neuropathic pain in CB1 knockout mice. Neuropharmacology, 50(1), 111-122. doi:10.1016/j.neuropharm.2005.07.022
  5. 134. Teixeira-Clerc, F., Julien, B., Grenard, P., Tran Van Nhieu, J., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006). Les antagonistes du récepteur CB1 des cannabinoïdes : une nouvelle approche pour le traitement de la fibrose hépatique. MS. Médecine sciences, 22(8-9), 683-685.
  6. 135. Laurent, P., Becker, J., Valverde, O., Ledent, C., de Kerchove d'Exaerde, A., Schiffmann, S. N., Maldonado, R., Vassart, G., & Parmentier, M. (2005). The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10. Nature neuroscience, 8(12), 1735-1741. doi:10.1038/nn1585
  7. 136. Jardinaud, F., Crété, D., Canestrelli, C., Ledent, C., Roques, B. P., & Noble, F. (2005). CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited. Brain research, 1063(1), 77-83. doi:10.1016/j.brainres.2005.09.015
  8. 137. Urigüen, L., Berrendero, F., Ledent, C., Maldonado, R., & Manzanares, J. (2005). Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice. European journal of neuroscience, 22(8), 2106-2110. doi:10.1111/j.1460-9568.2005.04372.x
  9. 138. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., & Vaugeois, J.-M. (2005). Reduced appetite for caffeine in adenosine A(2A) receptor knockout mice. European journal of pharmacology, 519(3), 290-291. doi:10.1016/j.ejphar.2005.07.022
  10. 139. Soria, G., Mendizábal, V., Touriño, C., Robledo, P., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2005). Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Biological psychiatry, 30(9), 1670-1680. doi:10.1038/sj.npp.1300707
  11. 140. Haller, J., Szirmai, M., Varga, B., Ledent, C., & Freund, T. F. (2005). Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia. Behavioural pharmacology, 16(5-6), 415-422.
  12. 141. Bodor, Á. L., Katona, I., Nyíri, G., Mackie, K., Ledent, C., Hájos, N., & Freund, T. F. (2005). Endocannabinoid signaling in rat somatosensory cortex: Laminar differences and involvement of specific interneuron types. The Journal of neuroscience, 25(29), 6845-6856. doi:10.1523/JNEUROSCI.0442-05.2005
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>